| Literature DB >> 31700812 |
Zijun Guo1, Mei Jiang1, Wenting Luo1, Peiyan Zheng1, Huimin Huang1, Baoqing Sun1.
Abstract
BACKGROUND: We aimed to investigate the association between lung cancer and tea-drinking habits of different subgroup populations.Entities:
Keywords: Case-control studies; Cohort studies; Lung cancer; Meta-analysis; Tea
Year: 2019 PMID: 31700812 PMCID: PMC6825660
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Fig. 1:Process followed in the selection of studies
Characteristics of published studies on tea consumption and lung cancer risk
| Romain 2016( | 1996–2001 | Canada | PCC | 1111/1469 | Black | 0. 71[0. 61, 0. 83] | 8 |
| Wu 2015( | 2001–2010 | China | PCC | 117/1196 | Green | 0. 87[0. 70, 1. 07] | 7 |
| Wang 2015( | 2012–2014 | China | HCC | 88/84 | Tea | 0. 97[0. 53, 1. 76] | 7 |
| Mai 2015( | 1992–2011 | US | Cohort | 1137/94887 | Tea | 0. 83[0. 71, 0. 96] | 8 |
| Katarzyna 2015( | 2014 | Poland | PCC | 92/156 | Green | 0. 49[0. 26, 0. 93] | 7 |
| Bao 2014( | 2010–2013 | China | HCC | 50/50 | Green | 0. 22[0. 08, 0. 60] | 7 |
| Rup 2014( | 2009–2012 | India | PCC | 230/460 | Tea | 0. 95[0. 61, 1. 49] | 7 |
| P. gnagna 2013( | 2004–2005 | Italy | Cohort | 178/4158 | Tea | 0. 72[0. 52, 0. 99] | 8 |
| Xu 2013( | 2006–2012 | China | HCC | 1225/1234 | Tea | 0. 98[0. 84, 1. 15] | 7 |
| Yumie 2013( | 2002–2009 | China | Cohort | 359/60733 | Tea | 0. 66[0. 53, 0. 83] | 7 |
| Jin 2013( | 2003–2010 | China | PCC | 1424/4543 | Green | 1. 05[0. 92, 1. 20] | 8 |
| Yumiel 2013( | 2001–2011 | China | Cohort | 428/70839 | Tea | 1. 00[0. 81, 1. 23] | 7 |
| Lin 2012( | 2004–2008 | China | HCC | 170/340 | Green | 0. 34[0. 21, 0. 55] | 7 |
| Zhang 2012( | 1997–2009 | China | PCC | 900/133811 | Tea | 1. 16[1. 01, 1. 32] | 8 |
| Bganesh 2011( | 1997–1999 | India | HCC | 408/1383 | Tea | 0. 24[0. 11, 0. 55] | 6 |
| Jiang 2011( | 2009–2011 | China | HCC | 100/100 | Tea | 0. 92[0. 53, 1. 61] | 7 |
| Lu 2009( | 1992–1995 | US | Cohort | 201/38207 | Tea | 0. 81[0. 61, 1. 08] | 7 |
| Han 2008( | 2003–2008 | China | HCC | 523/1924 | Green | 0. 56[0. 44, 0. 73] | 7 |
| Zhang 2008( | 2002–2006 | China | PCC | 505/529 | Tea | 1. 16[0. 89, 1. 53] | 8 |
| Wang 2008( | 2006 | China | HCC | 363/363 | Tea | 0. 60[0. 44, 0. 82] | 7 |
| Qli 2008( | 1994–2001 | Japan | cohort | 302/41138 | Green | 1. 29[0. 98, 1. 69] | 8 |
| Yan 2008( | 1999–2004 | US | PCC | 558/837 | Green&Black | 0. 52[0. 42, 0. 66] | 7 |
| Tao 2007( | 2002–2006 | China | HCC | 47/94 | Tea | 0. 72[0. 31, 1. 70] | 6 |
| Shinchi 2006( | 1995–2005 | Japan | Cohort | 222/16247 | Green | 1. 13[0. 82, 1. 56] | 8 |
| Hu 2002( | 1994–1997 | Canada | PCC | 161/483 | Tea | 0. 52[0. 34, 0. 81] | 8 |
| Mattew 2005( | 1995–1996 | China | PCC | 122/121 | Green | 0. 83[0. 44, 1. 54] | 7 |
| Ja 2005( | 1982–1998 | US | PCC | 993/986 | Black | 0. 95[0. 79, 1. 13] | 6 |
| Nagano 2001( | 1979–1994 | Japan | Cohort | 395/35930 | Green | 0. 86[0. 66, 1. 12] | 9 |
| Zhong 2001( | 1992–1994 | China | PCC | 649/675 | Green | 0. 97[0. 74, 1. 26] | 7 |
| Hivonen 2001( | 1995–1998 | Finland | PCC | 791/25643 | Tea | 0. 66[0. 53, 0. 81] | 7 |
| Kei 2000( | 1986–1997 | Japan | Cohort | 69/9483 | Green | 1. 01[0. 62, 1. 63] | 6 |
| Ki 1997( | 1992–1993 | China | HCC | 105/105 | Tea | 0. 50[0. 23, 1. 10] | 7 |
| Fredrik 1998( | 1989–1995 | Sweden | PCC | 124/235 | Black | 1. 23[0. 78, 1. 96] | 8 |
| Maria 1998( | 1994–1996 | Uruguay | HCC | 427/428 | Black | 0. 78[0. 60, 1. 02] | 7 |
| Alexandra 1996( | 1986–1990 | Netherlands | Cohort | 764/120088 | Black | 0. 58[0. 49, 0. 70] | 8 |
| Zheng 1996( | 1986–1993 | US | Cohort | 312/35057 | Black | 0. 78[0. 62, 0. 99] | 7 |
| Gosta 1996( | 1989–1993 | Sweden | PCC | 308/504 | Black | 0. 71[0. 53, 0. 94] | 7 |
| Xu 1996( | 1987–1993 | China | PCC | 598/926 | Tea | 0. 84[0. 68, 1. 03] | 9 |
| Ohno 1995( | 1988–1991 | Japan | PCC | 333/666 | Tea | 0. 57[0. 39, 0. 83] | 9 |
| Tewes 1990( | 1981–1983 | China | PCC | 200/200 | Green&Black | 0. 98[0. 66, 1. 45] | 6 |
| Mettlin 1989( | 1982–1987 | US | HCC | 569/569 | Tea | 0. 71[0. 56, 0. 91] | 6 |
| Kinlen 1988( | 1969–1986 | UK | Cohort | 718/12868 | Tea | 1. 67[1. 31, 2. 13] | 7 |
PCC, population-based case-control study; HCC, hospital-based case-control study; US, United States; UK, United Kingdom
Fig. 2:Association between tea consumption and OR for lung cancer
Fig. 3:Funnel plot of studies on tea consumption and lung cancer
Subgroup analyses of tea intake and lung cancer risk
| All studies | 42 | 0. 80[0. 73, 0. 87] | 19433/718854 | 80 | <0. 01 |
| 2. 5g/day | 25 | 0. 79[0. 68, 0. 91] | 10932/404166 | 82 | <0. 01 |
| Cohort | 10 | 0. 89[0. 71, 1. 11] | 4888/394604 | 87 | <0. 01 |
| CC | 15 | 0. 71[0. 58, 0. 87] | 6044/9562 | 79 | <0. 01 |
| 7. 5g/day | 16 | 0. 82[0. 67, 1. 01] | 7652/277373 | 86 | <0. 01 |
| Cohort | 6 | 0. 87[0. 60, 1. 28] | 2470/234754 | 93 | <0. 01 |
| CC | 10 | 0. 91[0. 70, 1. 18] | 4904/54490 | 80 | <0. 01 |
| Tea types | |||||
| Green tea | 14 | 0. 75[0. 61, 0. 92] | 5750/111640 | 84 | <0. 01 |
| Cohort | 4 | 1. 02[0. 81, 1. 28] | 988/101798 | 51 | 0. 1 |
| CC | 10 | 0. 79[0. 73, 0. 86] | 4762/9842 | 86 | <0. 01 |
| 2. 5g/day | 9 | 0. 73[0. 54, 0. 98] | 1959/104387 | 76 | <0. 01 |
| Cohort | 4 | 1. 00[0. 87, 1. 15] | 1511/103722 | 49 | 0. 1 |
| CC | 5 | 0. 41[0. 21, 0. 80] | 971/2589 | 73 | <0. 01 |
| 7. 5g/day | 7 | 0. 69[0. 48, 0. 98] | 1667/103926 | 84 | <0. 01 |
| Cohort | 4 | 0. 86[0. 74, 0. 98] | 988/101798 | 90 | <0. 01 |
| CC | 3 | 0. 61[0. 44, 0. 85] | 679/2128 | 59 | 0. 09 |
| Black tea | 9 | 0. 80[0. 70, 0. 91] | 4797/159909 | 65 | <0. 01 |
| Cohort | 2 | 0. 78[0. 72, 0. 84] | 1076/155250 | 72 | 0. 05 |
| CC | 7 | 0. 82[0. 76, 0. 90] | 3721/4659 | 45 | 0. 09 |
| 2. 5g/day | 7 | 0. 88[0. 68, 1. 14] | 4039/158872 | 87 | <0. 01 |
| Cohort | 2 | 0. 76[0. 44, 1. 29] | 1076/155250 | 90 | <0. 01 |
| CC | 5 | 0. 94[0. 72, 1. 23] | 2963/3622 | 79 | <0. 01 |
| 7. 5g/day | 5 | 0. 75[0. 56, 1. 02] | 2805/157168 | 78 | <0. 01 |
| Cohort | 2 | 0. 81[0. 49, 1. 36] | 1077/155250 | 67 | 0. 08 |
| CC | 3 | 0. 68[0. 40, 1. 16] | 1728/1918 | 73 | 0. 02 |
| Tea unknown | 21 | 0. 84[0. 73, 0. 96] | 8627/316770 | 78 | <0. 01 |
| Cohort | 4 | 0. 77[0. 70, 0. 86] | 2056/254560 | 0 | 0. 39 |
| CC | 17 | 0. 89[0. 83, 0. 95] | 7526/119181 | 76 | <0. 01 |
| 2. 5g/day | 9 | 0. 75[0. 59, 0. 96] | 4934/140907 | 84 | <0. 01 |
| Cohort | 4 | 0. 86[0. 56, 1. 32] | 2824/137556 | 92 | <0. 01 |
| CC | 6 | 0. 67[0. 58, 0. 78] | 2110/3351 | 20 | 0. 29 |
| 7. 5g/day | 5 | 1. 13[0. 81, 1. 57] | 4258/27690 | 83 | <0. 01 |
| Cohort | 1 | 1. 67[1. 31, 2. 13] | 718/12868 | - | - |
| CC | 4 | 1. 01[0. 71, 1. 43] | 2462/3411 | 79 | <0. 01 |
| Study design | |||||
| Cohort | 12 | 0. 88[0. 74, 1. 05] | 5085/538740 | 84 | <0. 01 |
| CC | 30 | 0. 76[0. 68, 0. 85] | 14578/180574 | 78 | <0. 01 |
| Geographical region | |||||
| Western population | 15 | 0. 81[0. 70, 0. 94] | 7325/329216 | 79 | <0. 01 |
| Cohort | 6 | 0. 93[0. 74, 1. 16] | 3310/299387 | 83 | <0. 01 |
| CC | 9 | 0. 73[0. 61, 0. 88] | 4015/29829 | 73 | <0. 01 |
| Asian population | 25 | 0. 80[0. 70, 0. 92] | 10630/321441 | 80 | <0. 01 |
| Cohort | 5 | 0. 94[0. 91, 0. 98] | 1416/172637 | 91 | <0. 01 |
| CC | 20 | 0. 96[0. 94, 0. 99] | 9214/148804 | 75 | <0. 01 |
| Sex | |||||
| Male | 11 | 0. 82[0. 64, 1. 05] | 5183/240914 | 90 | <0. 01 |
| Cohort | 4 | 1. 00[0. 61, 1. 61] | 1980/150566 | 94 | <0. 01 |
| CC | 7 | 0. 73[0. 55, 0. 98] | 3203/90348 | 87 | <0. 01 |
| Female | 14 | 0. 80[0. 67, 0. 95] | 4447/304808 | 64 | <0. 01 |
| Cohort | 5 | 0. 93[0. 82, 1. 06] | 1105/228461 | 19 | 0. 29 |
| CC | 8 | 0. 90[0. 82, 0. 97] | 3073/76121 | 28 | 0. 21 |
| Smoking status | |||||
| Smoking | 8 | 0. 80[0. 63, 1. 01] | 3663/32347 | 79 | <0. 01 |
| Cohort | 2 | 0. 67[0. 56, 0. 81] | 969/29801 | 0 | 0. 65 |
| CC | 5 | 0. 85[0. 63, 1. 15] | 2694/2546 | 80 | <0. 01 |
| No-smoking | 8 | 0. 67[0. 51, 0. 89] | 2973/74512 | 81 | <0. 01 |
| Cohort | 1 | 0. 66[0. 53, 0. 83] | 359/60733 | - | - |
| CC | 7 | 0. 63[0. 46, 0. 85] | 2545/3673 | 77 | <0. 01 |
| Study period | |||||
| Before 2000 | 22 | 0. 80[0. 70, 0. 91] | 9660/326269 | 77 | <0. 01 |
| Cohort | 7 | 0. 91[0. 67, 1. 23] | 2761/291876 | 89 | <0. 01 |
| CC | 15 | 0. 76[0. 67, 0. 85] | 6899/34393 | 57 | <0. 01 |
| After 2000 | 15 | 0. 75[0. 64, 0. 89] | 7422/147484 | 81 | <0. 01 |
| Cohorts | 2 | 0. 87[0. 63, 1. 20] | 606/74997 | 66 | <0. 01 |
| CC | 13 | 0. 74[0. 61, 0. 91] | 6457/11754 | 83 | <0. 01 |
CC, case-control study
Fig. 4:Association of between 2. 5g/day tea consumption and risk for lung cancer on smoking status